Fundz

Pharmazz reported raising $450,000 in an initial SEC Form D filing, from an offering of $15 Million

PRIVATENov 02, 2023$450K of $15M raised

Amount Raised

$450,000

$450,000 sold, per SEC Form D (first sale Oct 24, 2023)

Round Type

Seed

WillowbrookBiotechnologyHealthcareHealth Care

Quick answer

Pharmazz raised $450,000 in a Seed round, dated October 24, 2023. Pharmazz is based in Willowbrook, Illinois, United States.

How much did Pharmazz raise?
Pharmazz raised $450,000 in a Seed round on October 24, 2023.
What does Pharmazz do?
Pharmazz is a privately held company developing novel products in critical care medicine.
Where is Pharmazz based and how big is it?
Pharmazz is based in Willowbrook, Illinois, United States. Fundz records about 51 employees.
Who are the decision-makers at Pharmazz?
Fundz holds 3 contacts at Pharmazz, including the Managing Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Biotechnology around the same time

Companies in the same sectors as Pharmazz that raised within 45 days of this round, from Fundz verified event records.

  • Phio Pharmaceuticals raised $533K (Seed) on December 8, 2023.
  • Os Therapies raised $700K on December 8, 2023.
  • INTRINSIC THERAPEUTICS raised $55M on November 30, 2023.
  • Tenon Medical raised $1.3M (Seed) on November 21, 2023.
  • Greenbrook TMS raised $2.5M (Seed) on November 16, 2023.
  • Route 92 Medical raised $31M (Series F) on November 16, 2023.

Who to call at Pharmazz, and when

A new round usually means Pharmazz is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Pharmazz raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Pharmazz, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Pharmazz. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Pharmazz

Location

50 W 75TH ST

Willowbrook, Illinois, United States

About

Pharmazz is a privately held company developing novel products in critical care medicine. The U.S. Food and Drug Administration (FDA) has approved two phase III INDs for Centhaquine as an agent for hypovolemic shock and Sovateltide for cerebral ischemic stroke. In addition, Pharmazz obtained marketing authorization for two of its first-in-class drug molecules, Centhaquine and Sovateltide, for hypovolemic shock and ischemic stroke, respectively, in India. Pharmazz has partnered with Sun Pharmaceutical to market Sovateltide for cerebral ischemic stroke patients in India. In addition, Pharmazz has partnered with Dr. Reddy's Laboratories to market Centhaquine, a resuscitative agent, in India.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Pharmazz raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

3 contacts
Verified contactsManish L., Managing Director hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Pharmazz's next move

See what Strategic adds

Pharmazz raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.